1. We shouldn't make recommendations for drugs being tested to treat COVID until trials are complete  ThePrint
  2. How One Indian Company Could Be World's Door to a COVID-19 Vaccine  The New York Times
  3. INSIGHT-How one Indian company could be world's door to a COVID-19 vaccine  Yahoo Finance
  4. We must be very careful & manage people's expectation regarding the Covid vaccine : Adar Poonawalla  ThePrint
  5. COVID-19 vaccine development at early stage in India; breakthrough unlikely within a year: Experts  Moneycontrol
  6. View Full coverage on Google News
If the world is to gain access to a vaccine for COVID-19, there's a good chance it will pass through the doors of Serum Institute of India.If the world is to gain access to a vaccine for COVID-19, there's a good chance it will pass through the doors of Serum Institute of India.

If the world is to gain access to a vaccine for COVID-19, there's a good chance it will pass through the doors of Serum Institute of India. Serum Institute, the world's largest manufacturer of vaccines by volume, is working on several candidates for the novel coronavirus - including potentiallyIf the world is to gain access to a vaccine for COVID-19, there's a good chance it will pass through the doors of Serum Institute of India. Serum Institute, the world's largest manufacturer of vaccines by volume, is working on several candidates for the novel coronavirus - including potentially

INSIGHT-How one Indian company could be world's door to a COVID-19 vaccine

Here is a preview of the top Covid-19 news today from India and the world.Here is a preview of the top Covid-19 news today from India and the world.

RBI cuts key rate, Oxford vaccine trials in next phase: Covid-19 news today - india news - Hindustan Times

“Ignore hype and euphoria over any Covid vaccine news for next 2-3 months: @adarpoonawalla, CEO, Serum Institute of India, at #ThePrintOTC Sandhya Ramesh @sandygrains and @MohanaBasu report https://t.co/7nTkNRrLTy”

Shekhar Gupta on Twitter: "Ignore hype and euphoria over any Covid vaccine news for next 2-3 months: @adarpoonawalla, CEO, Serum Institute of India, at #ThePrintOTC Sandhya Ramesh @sandygrains and @MohanaBasu report https://t.co/7nTkNRrLTy"

“Every midnight, Umesh Shaligram, R&D head at Serum Institute of India, world’s biggest #vaccine maker, gets a WhatsApp from govt - usually PM Modi’s top scientific adviser - for updates on the #COVID19 vaccine he's rushing to develop, any hurdles. https://t.co/lkFP5PCvqB @Reuters”

William Mallard on Twitter: "Every midnight, Umesh Shaligram, R&D head at Serum Institute of India, world’s biggest #vaccine maker, gets a WhatsApp from govt - usually PM Modi’s top scientific adviser - for updates on the #COVID19 vaccine he's rushing to develop, any hurdles. https://t.co/lkFP5PCvqB @Reuters"

“India quietly plays a key role in manufacturing 60%-70% of all vaccines sold globally with the Serum Institute playing a lead role https://t.co/fn8jcXHdXY”

Jeff Ballinger on Twitter: "India quietly plays a key role in manufacturing 60%-70% of all vaccines sold globally with the Serum Institute playing a lead role https://t.co/fn8jcXHdXY"

Serum Institute chief says the potential vaccine is based on a tried-and-tested platformSerum Institute chief says the potential vaccine is based on a tried-and-tested platform

Coronavirus | 80% success chance for Oxford vaccine trials, says Serum Institute chief - The Hindu

At the company's sprawling, 150-acre campus in the western Indian city of Pune, Shaligram and his team are working flat-out..Serum Institute. Pune-based firm. COVID-19 vaccine. coronavirus vaccine.Business News. Finance NewsAt the company's sprawling, 150-acre campus in the western Indian city of Pune, Shaligram and his team are working flat-out..Serum Institute. Pune-based firm. COVID-19 vaccine. coronavirus vaccine.Business News. Finance News

How a Pune-based firm may open the world's door to a COVID-19 vaccine | Business News | English Manorama

Health: INSIGHT: How one Indian company could be world's door to a Covid-19 vaccine

Research on a COVID-19 vaccine in India is at a very early stage of development and any candidates are likely to reach animal trials only by the end of the year, says leading virologist Shahid JameelResearch on a COVID-19 vaccine in India is at a very early stage of development and any candidates are likely to reach animal trials only by the end of the year, says leading virologist Shahid Jameel

Coronavirus vaccine development in India unlikely within a year, say experts

India Business News: Serum Institute, the world's largest manufacturer of vaccines by volume, is working on several candidates for the novel coronavirus - including potentIndia Business News: Serum Institute, the world's largest manufacturer of vaccines by volume, is working on several candidates for the novel coronavirus - including potent

How one Indian company could be world's door to a Covid-19 vaccine - Times of India

The Indian government and private firms have stepped up efforts to develop a vaccine to halt the spread of Covid-19 which has claimed over 3,700 lives with more than 1,25,000 cases in the country.The Indian government and private firms have stepped up efforts to develop a vaccine to halt the spread of Covid-19 which has claimed over 3,700 lives with more than 1,25,000 cases in the country.

Covid-19 Vaccine Development at Early Stage in India But Breakthrough Unlikely Within a Year

Serum Institute, the world's largest manufacturer of vaccines by volume, is working on several candidates for the novel coronavirus.Serum Institute, the world's largest manufacturer of vaccines by volume, is working on several candidates for the novel coronavirus.

An Indian company could be world's door to a Covid-19 vaccine - News | Khaleej Times

As Indian firms scramble to develop a vaccine for coronavirus, experts feel that research in the country is still at a nascent stage and any concrete breakthroughAs Indian firms scramble to develop a vaccine for coronavirus, experts feel that research in the country is still at a nascent stage and any concrete breakthrough

COVID-19 vaccine development at early stage in India; breakthrough unlikely within a year, say experts | Business Insider India

As Indian firms scramble to develop a vaccine for coronavirus, experts feel that research in the country is still at a nascent stage and any concrete breakthrough is not likely within a year. Follow latest updates on the COVID-19 pandemic hereAs Indian firms scramble to develop a vaccine for coronavirus, experts feel that research in the country is still at a nascent stage and any concrete breakthrough is not likely within a year. Follow

Breakthrough unlikely within a year; COVID-19 vaccine development at early stage in India: Experts | Deccan Herald

Serum Institute, the world's largest manufacturer of vaccines by volume, is working on several candidates for the novel coronavirus - including potentially mass-producing the AstraZeneca/Oxford university one that has garnered global headlines - as well as developing its own.Get latest Healthcare online at cnbctv18.com Serum Institute, the world's largest manufacturer of vaccines by volume, is working on several candidates for the novel coronavirus - including potentially mass-producing the AstraZeneca/Oxford university one that has garnered global headlines - as well as developing its own.Get latest Healthcar

How this Indian company could be world's door to a COVID-19 vaccine - cnbctv18.com